Skip to main content

BD to Distribute Epistem TB Test

NEW YORK (GenomeWeb News) – Epistem said today that Becton Dickinson will distribute the firm's Mycobacterium tuberculosis test on a global basis, excluding India and the Indian Sub-Continent.

The molecular test, which recently received the CE-IVD Mark, runs on Epistem's Genedrive platform.

Manchester, UK-based Epistem said that it will receive an upfront payment of $1 million and further milestone payments up to $3 million. In addition, the agreement includes escalating supply volumes over the next five years.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.